Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas

Clinical trial NCT00612638 · COMPLETED

Trial details

NCT number: NCT00612638
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma

Start date: 2005-01-01
Primary completion: 2007-01-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.